Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic acid to prevent postoperative delirium after cardiovascular surgery in elderly patients
jRCTs031220690Completed
- Sponsor
- Grants-in-Aid for Scientific Research
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ascorbic acid in postoperative delirium (POD) and delirium, sponsored by Grants-in-Aid for Scientific Research. Primary endpoint: incidence of postoperative delirium. Started Mar 2023; status: completed.
02
Drugs
ascorbic acid
03
Conditions
postoperative delirium (POD)delirium
Beyond the preview
Go deeper on jRCTs031220690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220690.